Case report: Importance of early and continuous tocilizumab therapy in nephrotic syndrome associated with idiopathic multicentric Castleman disease: A case series
Daiki Kojima(Keio University), Hiroshi Itoh(Keio University), K Nishioka, Takashin Nakayama(Keio University Hospital), Kohkichi Morimoto(Keio University), Kaori Hayashi(Akita University), Shintaro Yamaguchi(Keio University), Norifumi Yoshimoto(Keio University), Toshiaki Monkawa(Tokyo University of Science), Kiyotaka Uchiyama(Japanese Red Cross Medical Center), Jun Yoshino(Shimane University Hospital), Takeshi Kanda(Shimane University Hospital), Takaya Tajima(Keio University), Tadashi Yoshida(Keio University), Keika Adachi(Keio University), Akinori Hashiguchi
Cited by 1
Related Papers
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice
|Cell Metabolism|2011|1.3k
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD <sup>+</sup> Biosynthesis
|Science|2009|1.1k
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
|Cell Metabolism|2017|1k